Ra Pharmaceuticals, Inc. (RARX) has 58 open-market insider trades by 27 insiders since 2016. The most active filer is Ramin Farzaneh-Far.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rajeev M. Shah | Dir10% Owner | — | 3 | $32.7M | 2020-04-02 |
| NEA Partners 13, Limited Partnership | 10% Owner | — | 1 | $20.0M | 2018-12-14 |
| RA Capital Management, LLC via Rajeev M. Shah | Dir10% Owner | — | 1 | $15.6M | 2018-12-12 |
| Peter Kolchinsky | Dir10% Owner | — | 1 | $15.0M | 2018-02-14 |
| NEA 13 GP, Ltd | 10% Owner | — | 2 | $12.0M | 2020-04-02 |
| Ag Novartis | 10% Owner | — | 10 | $11.9M | 2017-06-19 |
| Jason Lettmann | Dir | — | 1 | $10.2M | 2016-10-31 |
| Forest Baskett | 10% Owner | — | 1 | $8.8M | 2016-10-31 |
| Ramin Farzaneh-Far | — | — | 14 | $5.5M | 2020-04-02 |
| David M. Mott | 10% Owner | — | 1 | $4.4M | 2016-10-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alonso Ricardo | — | Sell | $101K | 2020-03-17 |
| Ramin Farzaneh-Far | — | Sell | $957K | 2020-03-16 |
| Ramin Farzaneh-Far | — | Sell | $988K | 2020-02-18 |
| Alonso Ricardo | — | Sell | $215K | 2020-01-17 |
| Ramin Farzaneh-Far | — | Sell | $995K | 2020-01-15 |
| Simon Read | CSO | Sell | $471K | 2019-12-17 |
Companies that share insiders with RARX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Alonso Ricardo | — | Sell | $215K | 2019-12-17 |
| Ramin Farzaneh-Far | — | Sell | $500K | 2019-12-16 |
| Ramin Farzaneh-Far | — | Sell | $1.0M | 2019-12-16 |
| Ramin Farzaneh-Far | — | Sell | $989K | 2019-11-15 |
| Simon Read | CSO | Sell | $467K | 2019-11-14 |
| Alonso Ricardo | — | Sell | $213K | 2019-10-17 |
| Simon Read | CSO | Sell | $469K | 2019-10-16 |
| Ramin Farzaneh-Far | — | Sell | $994K | 2019-10-15 |
| Ramin Farzaneh-Far | — | Sell | $535K | 2019-09-16 |